Forest Laboratories, Inc. (FRX) Announces New FETZIMA™ (levomilnacipran ER capsules) Now Available In Pharmacies Throughout U.S.  
12/19/2013 9:58:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX) announced today that FETZIMA™ (levomilnacipran ER capsules), is now available in pharmacies throughout the United States. FETZIMA was approved by the U.S. Food and Drug Administration (FDA) for the treatment of Major Depressive Disorder (MDD), also known as depression, in adults in July 2013.

Help employers find you! Check out all the jobs and post your resume.